Details
Stereochemistry | ACHIRAL |
Molecular Formula | O4Se.2H4N |
Molecular Weight | 179.03 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[NH4+].[NH4+].[O-][Se]([O-])(=O)=O
InChI
InChIKey=ZBIBSMMVRNDSNI-UHFFFAOYSA-N
InChI=1S/2H3N.H2O4Se/c;;1-5(2,3)4/h2*1H3;(H2,1,2,3,4)
Molecular Formula | H2O4Se |
Molecular Weight | 144.97 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H3N |
Molecular Weight | 17.0305 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/19827742Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24323428 | https://www.ncbi.nlm.nih.gov/pubmed/26468123 | https://www.ncbi.nlm.nih.gov/pubmed/25485856
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19827742
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24323428 | https://www.ncbi.nlm.nih.gov/pubmed/26468123 | https://www.ncbi.nlm.nih.gov/pubmed/25485856
SELENATE ION is a compound containing an oxoanion with selenium in its highest oxidation state of VI. Selenates are analogous to sulfates and have similar chemistry, but unlike sulfate, selenate is a good oxidizer. Selenate is the form required by organisms that need selenium as a micronutrient. These organisms have the ability to acquire, metabolize and excrete selenium. The level at which selenium becomes toxic varies from species to species and is related to other environmental factors like pH and alkalinity that influence the concentration of selenite over selenate. Selenate and other forms of selenium are highest in areas where ancient seas have evaporated. These areas are enriched in selenium and over millennia, biologic adaptation has occurred.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP402 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18547722 |
|||
Target ID: CHEMBL4703 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20643941 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00271245
200-400 µg selenium as selenate
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25485856
N2aSW cell viability was detected by the CCK-8 assay. Briefly, N2aSW cells (5X10^3 per well) exposed to sodium selenate at a set of concentrations (0.00001, 0.0001, 0.001, 0.01, 0.1, 1, 10 mmol/L in FBS-free medium) were grown in 96-well-plates for 24 h. 10% CCK-8 reagent was added to each well and the cells were incubated at 37°C for another 2 h. Cells without sodium selenate treatment were used as the control. The absorbance at 450 nm was measured with a reference wavelength of 650 nm by SpecTRA MAX 190 microplate reader (Molecular Devices, Sunnyvale, CA, USA). All experiments were performed in triplicates.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:09:37 GMT 2023
by
admin
on
Sat Dec 16 02:09:37 GMT 2023
|
Record UNII |
02E09D6S55
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m1818
Created by
admin on Sat Dec 16 02:09:37 GMT 2023 , Edited by admin on Sat Dec 16 02:09:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
02E09D6S55
Created by
admin on Sat Dec 16 02:09:37 GMT 2023 , Edited by admin on Sat Dec 16 02:09:37 GMT 2023
|
PRIMARY | |||
|
231-985-7
Created by
admin on Sat Dec 16 02:09:37 GMT 2023 , Edited by admin on Sat Dec 16 02:09:37 GMT 2023
|
PRIMARY | |||
|
165640
Created by
admin on Sat Dec 16 02:09:37 GMT 2023 , Edited by admin on Sat Dec 16 02:09:37 GMT 2023
|
PRIMARY | |||
|
DTXSID40889578
Created by
admin on Sat Dec 16 02:09:37 GMT 2023 , Edited by admin on Sat Dec 16 02:09:37 GMT 2023
|
PRIMARY | |||
|
7783-21-3
Created by
admin on Sat Dec 16 02:09:37 GMT 2023 , Edited by admin on Sat Dec 16 02:09:37 GMT 2023
|
PRIMARY |